Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs.
Journal for immunotherapy of cancer
Zhang, Tian T, Forde, Patrick M PM, Sullivan, Ryan J RJ, Sharon, Elad E, Barksdale, Elizabeth E, Selig, Wendy W, Ebbinghaus, Scot S, Fusaro, Gina G, Gunenc, Damla D, Battle, Dena D, Burns, Robyn R, Hurlbert, Marc S MS, Stewart, Mark M, Atkins, Michael B MB